Tradestie Institutional Equity Comparison Engine

KTTA vs SBEV โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KTTA Overall Edge

KTTA Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pasithea Therapeutics Corp. Common Stock (KTTA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, KTTA trades at N/M Forward P/E with 0.0% operating margin (+1498.1% YoY revenue) versus SBEV at N/M Forward P/E and -23888.5% operating margin (-93.8% YoY). In options structure, KTTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SBEV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
KTTA N/M vs SBEV N/M Fwd P/E
Growth & Margin Winner KTTA
Op Margin 0.0% vs -23888.5% ยท YoY +1498.1% vs -93.8%
Momentum & Technical Winner KTTA
1Y +0.6% vs -73.4% ยท 52W Pos 11% vs 12%
Options & Structure Winner KTTA
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
KTTA NASDAQ
Pasithea Therapeutics Corp. Common Stock
Pharmaceutical Preparations
$0.48
-0.48% 1D
Market Cap $17.7M
1M Return +7.52%
1Y Return +0.59%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 20.0 Fund 40.0 Flow 50.0 Mom 60.0
SBEV NYSE American
Splash Beverage Group, Inc.
Beverages
$0.47
+10.94% 1D
Market Cap $2.7M
1M Return +358.21%
1Y Return -73.38%
Forward P/E N/M
Unified AI Score
36.4 / 100 SELL
Tech 15.0 Fund 32.0 Flow 44.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: KTTA +0.59% SBEV -73.38% Spread: +61.13 pp (KTTA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period KTTA Revenue SBEV Revenue KTTA Op. Margin SBEV Op. Margin Margin Edge
FY2018 N/A $0M N/A 5.1% SBEV
FY2019 N/A $0M N/A -22009.4% SBEV
FY2020 N/A $0M N/A -767.9% SBEV
FY2021 $0M $10M -29925.7% -257.0% SBEV
FY2022 $0M $20M -2587.3% -118.3% SBEV
FY2023 N/A $20M N/A -81.1% SBEV
FY2024 N/A $0M N/A -1235.6% SBEV
FY2025 N/A $0M N/A -19415.6% SBEV

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: KTTA (5) vs SBEV (2)
Institutional Metric KTTA SBEV Criterion Row Winner
Market Capitalization Scale $17.7M $2.7M Larger Scale KTTA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +1498.1% -93.8% Higher Growth KTTA
Operating Margin (TTM) Profitability 0.0% -23888.5% Higher Margin KTTA
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -88.8% -1130.2% Higher ROE KTTA
52-Week Range Position Momentum 11% ($0โ€“$2) 12% ($0โ€“$3) Stronger Trend SBEV
Beta / 30D Volatility Risk Regime 0.68ฮฒ ยท 185% Vol -1.41ฮฒ ยท 136% Vol Lower Realized Risk SBEV
Unified Institutional Score Composite Signal 42.1 / 100 (HOLD) 36.4 / 100 (SELL) Higher Composite KTTA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full KTTA vs SBEV Buy Guide
KTTA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live KTTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SBEV UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SBEV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither KTTA nor SBEV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.